Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Janet Nitta"'
Autor:
Mohamed Abuhaleeqa, Kristjan Paulson, Andrew Daly, Janet Nitta, Matthew D. Seftel, Yasser Abou Mourad, Craig Speziali
Publikováno v:
Leukemialymphoma. 60(3)
The optimal conditioning regimen for adults undergoing transplantation for acute lymphoblastic leukemia (ALL) remains undetermined. Cyclophosphamide and total body irradiation (Cy/TBI) has emerged as a standard myeloablative regimen but is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6cab0f5f378be994f9daa3fe9bca8d
https://pubmed.ncbi.nlm.nih.gov/30160568
https://pubmed.ncbi.nlm.nih.gov/30160568
Autor:
Ashley Morris, Mitchell E. Horwitz, Keith M. Sullivan, David A. Rizzieri, Gwynn D. Long, Nelson J. Chao, Donna E. Hogge, Junya Kanda, Donna Niedzwiecki, Janet Nitta, John P. Chute, Kevin W. Song, Cristina Gasparetto, Clayton A. Smith
Publikováno v:
Biology of Blood and Marrow Transplantation. 17:867-874
Abstract 3523 A high graft failure rate and treatment-related mortality (TRM) have historically been major pitfalls of myeloablative adult umbilical cord blood (UCB) transplantation. The goal of this prospective clinical trial was to identify an appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05990992d744f5769da29b7f9a62e5e4
https://doi.org/10.1016/j.bbmt.2010.09.009
https://doi.org/10.1016/j.bbmt.2010.09.009
Autor:
Andrew Daly, Matthew D. Seftel, Kristjan Paulson, Janet Nitta, Yasser Abou Mourad, Craig Speziali, Mohamed Abuhaleeqa
Publikováno v:
Blood. 128:663-663
Background: Allogeneic hematopoietic cell transplantation (HCT) is an important treatment for adults with acute lymphoblastic leukemia (ALL). The combination of cyclophosphamide with total body irradiation (TBI) at doses of 1200 to 1500 cGy (Cy/TBI12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a43148a429f22bc21a1d64425bd84524
https://doi.org/10.1182/blood.v128.22.663.663
https://doi.org/10.1182/blood.v128.22.663.663
Publikováno v:
Cytometry. Part B, Clinical cytometry. 82(5)
Accurate prediction of chemotherapy drug resistance would aid treatment decisions in acute myeloid leukemia (AML). The aim of this study was to determine if mitoxantrone efflux from AML blasts would correlate with response to induction chemotherapy.F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5088212f421ed42be230536dc5d32f4
https://pubmed.ncbi.nlm.nih.gov/22508650
https://pubmed.ncbi.nlm.nih.gov/22508650
Publikováno v:
American journal of hematology. 86(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3678a1b24fda0e560d8fa4d0bc749ff6
https://pubmed.ncbi.nlm.nih.gov/21805495
https://pubmed.ncbi.nlm.nih.gov/21805495
Autor:
Janet Nitta, Linda Hamata, Cynthia L. Toze, Kevin W. Song, Raewyn Broady, Donna E. Hogge, Yasser Abou Mourad, Heather J. Sutherland, Clayton A. Smith, Stephen H. Nantel, Christopher P. Venner, Maryse M. Power, John D. Shepherd, Sujaatha Narayanan, Thomas J. Nevill, Michael J. Barnett, Donna L. Forrest, Joseph M. Connors
Publikováno v:
Leukemialymphoma. 52(1)
The treatment of multiple myeloma (MM) has changed with the advent of thalidomide, bortezomib, and lenalidomide, the so-called novel agents (NAs). Given the complexity of MM therapy in the NA era we pursued a population based study to assess for impr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ef54b0666df636f98c906d73cb9745
https://pubmed.ncbi.nlm.nih.gov/21323515
https://pubmed.ncbi.nlm.nih.gov/21323515
Autor:
John D. Shepherd, Heather J. Sutherland, Michael J. Barnett, Clayton A. Smith, Yasser Abou Mourad, Maryse M. Power, Stephen H. Nantel, Janet Nitta, Yunfeng Dai, Thomas J. Nevill, Donna E. Hogge, Kevin W. Song, Julye C. Lavoie, Cynthia L. Toze, Donna L. Forrest
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(2)
The optimal therapy for myelodysplastic syndrome (MDS) is allogeneic bone marrow (BM) or blood (BSC) stem cell transplantation (SCT), although outcomes are limited by nonrelapse mortality (NRM) and relapse. A retrospective review was performed of 156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e890f4ef765b189fa4c09dc953c968d2
https://pubmed.ncbi.nlm.nih.gov/19167680
https://pubmed.ncbi.nlm.nih.gov/19167680
Autor:
Clayton A. Smith, John Kuruvilla, Stephen H. Nantel, Heather J. Sutherland, Aulan Le, Kevin W. Song, John D. Shepherd, Donna E. Hogge, Cynthia L. Toze, Julye C. Lavoie, Micheal J. Barnett, Thomas J. Nevill, Janet Nitta, Donna L. Forrest
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(8)
Allogeneic stem cell transplantation (alloSCT) has been used in the hopes of harnessing the curative potential of the graft-versus-myeloma effect. This study examines the long-term outcomes of a large cohort of patients with myeloma who were treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940d8fce3e06cdd437d424bebf37f252
https://pubmed.ncbi.nlm.nih.gov/17640596
https://pubmed.ncbi.nlm.nih.gov/17640596
Autor:
Heather J. Sutherland, Yves Chalandon, Douglas E. Horsman, Michael J. Barnett, Thomas J. Nevill, Cynthia L. Toze, Stephen H. Nantel, Donna E. Hogge, Eibhlin Conneally, John D. Shepherd, Janet Nitta
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 8(8)
Cytogenetic abnormalities detected at diagnosis are recognized as important in predicting response to chemotherapy in acute myeloid leukemia (AML). However, there is controversy concerning the prognostic significance of karyotype for outcome after al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7d759b3ef395332974bdf476b82077
https://pubmed.ncbi.nlm.nih.gov/12234169
https://pubmed.ncbi.nlm.nih.gov/12234169
Publikováno v:
Blood. 114:2916-2916
Abstract 2916 Poster Board II-892 Introduction: Essential thrombocythemia (ET) is a myeloproliferative neoplasm associated with increased risk of both venous and arterial thrombosis, hemorrhage and transformation to other myeloid disorders such as my
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6f440220b282627c738407a1717db1
https://doi.org/10.1182/blood.v114.22.2916.2916
https://doi.org/10.1182/blood.v114.22.2916.2916